Clinical Trial Update: Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating VLTS-934 for intermittent claudication due to peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• VLTS-934

Snippet

Sponsor: Valentis | Conditions: Peripheral Vascular Disease | Phase 2 | Status: COMPLETED